Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation - PubMed (original) (raw)
Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation
Eric N Churchill et al. Circ Res. 2005.
Abstract
Cardiac ischemia and reperfusion are associated with loss in the activity of the mitochondrial enzyme pyruvate dehydrogenase (PDH). Pharmacological stimulation of PDH activity improves recovery in contractile function during reperfusion. Signaling mechanisms that control inhibition and reactivation of PDH during reperfusion were therefore investigated. Using an isolated rat heart model, we observed ischemia-induced PDH inhibition with only partial recovery evident on reperfusion. Translocation of the redox-sensitive delta-isoform of protein kinase C (PKC) to the mitochondria occurred during reperfusion. Inhibition of this process resulted in full recovery of PDH activity. Infusion of the deltaPKC activator H2O2 during normoxic perfusion, to mimic one aspect of cardiac reperfusion, resulted in loss in PDH activity that was largely attributable to translocation of deltaPKC to the mitochondria. Evidence indicates that reperfusion-induced translocation of deltaPKC is associated with phosphorylation of the alphaE1 subunit of PDH. A potential mechanism is provided by in vitro data demonstrating that deltaPKC specifically interacts with and phosphorylates pyruvate dehydrogenase kinase (PDK)2. Importantly, this results in activation of PDK2, an enzyme capable of phosphorylating and inhibiting PDH. Thus, translocation of deltaPKC to the mitochondria during reperfusion likely results in activation of PDK2 and phosphorylation-dependent inhibition of PDH.
Similar articles
- Translocation of deltaPKC to mitochondria during cardiac reperfusion enhances superoxide anion production and induces loss in mitochondrial function.
Churchill EN, Szweda LI. Churchill EN, et al. Arch Biochem Biophys. 2005 Jul 15;439(2):194-9. doi: 10.1016/j.abb.2005.05.007. Arch Biochem Biophys. 2005. PMID: 15963450 - c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons.
Zhou Q, Lam PY, Han D, Cadenas E. Zhou Q, et al. J Neurochem. 2008 Jan;104(2):325-35. doi: 10.1111/j.1471-4159.2007.04957.x. Epub 2007 Oct 18. J Neurochem. 2008. PMID: 17949412 - Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia.
Shimohata T, Zhao H, Sung JH, Sun G, Mochly-Rosen D, Steinberg GK. Shimohata T, et al. J Cereb Blood Flow Metab. 2007 Aug;27(8):1463-75. doi: 10.1038/sj.jcbfm.9600450. Epub 2007 Feb 7. J Cereb Blood Flow Metab. 2007. PMID: 17293847 - PDH kinase inhibitors: a novel therapy for Type II diabetes?
Mayers RM, Leighton B, Kilgour E. Mayers RM, et al. Biochem Soc Trans. 2005 Apr;33(Pt 2):367-70. doi: 10.1042/BST0330367. Biochem Soc Trans. 2005. PMID: 15787608 Review. - Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1.
Semenza GL. Semenza GL. Biochem J. 2007 Jul 1;405(1):1-9. doi: 10.1042/BJ20070389. Biochem J. 2007. PMID: 17555402 Review.
Cited by
- Post-translational modifications of pyruvate dehydrogenase complex in cardiovascular disease.
Guo B, Zhang F, Yin Y, Ning X, Zhang Z, Meng Q, Yang Z, Jiang W, Liu M, Wang Y, Sun L, Yu L, Mu N. Guo B, et al. iScience. 2024 Jul 31;27(9):110633. doi: 10.1016/j.isci.2024.110633. eCollection 2024 Sep 20. iScience. 2024. PMID: 39224515 Free PMC article. Review. - Inhibition of Pyruvate Dehydrogenase Kinase 4 Protects Cardiomyocytes from lipopolysaccharide-Induced Mitochondrial Damage by Reducing Lactate Accumulation.
Chen T, Xie Q, Tan B, Yi Q, Xiang H, Wang R, Zhou Q, He B, Tian J, Zhu J, Xu H. Chen T, et al. Inflammation. 2024 Aug;47(4):1356-1370. doi: 10.1007/s10753-024-01981-z. Epub 2024 Feb 24. Inflammation. 2024. PMID: 38401019 - Metabolic Control of Cardiomyocyte Cell Cycle.
Menendez-Montes I, Garry DJ, Zhang JJ, Sadek HA. Menendez-Montes I, et al. Methodist Debakey Cardiovasc J. 2023 Nov 16;19(5):26-36. doi: 10.14797/mdcvj.1309. eCollection 2023. Methodist Debakey Cardiovasc J. 2023. PMID: 38028975 Free PMC article. Review. - Differential intracellular management of fatty acids impacts on metabolic stress-stimulated glucose uptake in cardiomyocytes.
Vanni E, Lindner K, Gavin AC, Montessuit C. Vanni E, et al. Sci Rep. 2023 Sep 8;13(1):14805. doi: 10.1038/s41598-023-42072-7. Sci Rep. 2023. PMID: 37684349 Free PMC article. - A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury.
Qvit N, Lin AJ, Elezaby A, Ostberg NP, Campos JC, Ferreira JCB, Mochly-Rosen D. Qvit N, et al. Pharmaceuticals (Basel). 2022 Feb 22;15(3):271. doi: 10.3390/ph15030271. Pharmaceuticals (Basel). 2022. PMID: 35337069 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources